Literature DB >> 11918529

Immunomodulatory gene therapy for haematological malignancies.

G D Schmidt-Wolf, I G H Schmidt-Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11918529     DOI： 10.1046/j.1365-2141.2002.03365.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines.

Authors:  Yutao Li; Amit Sharma; Maurits W J R Bloemendal; Roland Schmidt-Wolf; Miroslaw Kornek; Ingo G H Schmidt-Wolf
Journal:  Oncol Lett       Date:  2021-06-23       Impact factor: 2.967

2.  Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC.

Authors:  Oliver Ebert; Dorothee Wilbert; Peter Buttgereit; Carsten Ziske; Dimitri Flieger; Ingo Gh Schmidt-Wolf
Journal:  Genet Vaccines Ther       Date:  2004-10-14

Review 3.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Authors:  Ruan F V Medrano; Aline Hunger; Samir Andrade Mendonça; José Alexandre M Barbuto; Bryan E Strauss
Journal:  Oncotarget       Date:  2017-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.